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The prevalence of osteoporosis and the incidence of age-related fragility fracture vary by
ethnicity. There is greater than 10-fold variation in fracture probabilities between countries
across the world. Mineral and bone metabolism are intimately interlinked, and both are
known to exhibit patterns of daily variation, known as the diurnal rhythm (DR). Ethnic
differences are described for Ca and P metabolism. The importance of these differences
is described in detail between select ethnic groups, within the USA between African-
Americans and White-Americans, between the Gambia and the UK and between
China and the UK. Dietary Ca intake is higher in White-Americans compared with
African-Americans, and is higher in White-British compared with Gambian and Chinese
adults. Differences are observed also for plasma 25-hydroxy vitamin D, related to lifestyle
differences, skin pigmentation and skin exposure to UVB-containing sunshine. Higher
plasma 1,25-dihydroxy vitamin D and parathyroid hormone are observed in African-
American compared with White-American adults. Plasma parathyroid hormone is also
higher in Gambian adults and, in winter, in Chinese compared with White-British adults.
There may be ethnic differences in the bone resorptive effects of parathyroid hormone,
with a relative skeletal resistance to parathyroid hormone observed in some, but not all eth-
nic groups. Renal mineral excretion is also inﬂuenced by ethnicity; urinary Ca (uCa) and
urinary P (uP) excretions are lower in African-Americans compared with White-
Americans, and in Gambians compared with their White-British counterparts. Little is
known about ethnic differences in the DR of Ca and P metabolism, but differences may
be expected due to known differences in lifestyle factors, such as dietary intake and sleep/
wake pattern. The ethnic-speciﬁc DR of Ca and P metabolism may inﬂuence the net balance
of Ca and P conservation and bone remodelling. These ethnic differences in Ca, P and the
bone metabolism may be important factors in the variation in skeletal health.
Dietary intake: Diurnal rhythm: Calcium: Phosphate: Bone: Parathyroid hormone
Ethnicity is generally deﬁned as ‘the fact or sense of be-
longing to a particular ethnic group’(1). An ethnic group
shares a distinctive cultural and historical tradition, often
associated with nationality, or region by which the group
identiﬁes itself and others recognise it(1). This broad
concept of ethnicity, encapsulating culture, lifestyle,
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identiﬁcation, environment, biology and genetics, is what
we refer to in this review.
Ethnic differences in bone health
The prevalence of osteoporosis and the incidence of
age-related fragility fracture vary by ethnicity. Kanis
et al. report a greater than 10-fold variation in fracture
probability between countries across the world(2), and
substantial differences are also seen between ethnic
groups within a country. The age-adjusted incidence
rates of hip and distal-forearm fractures in elderly West
African men and women are shown to be substantially
lower than those found in Britain(3). Similarly, Yan
et al. have reported a low incidence of hip fracture in
Northern China, and the overall male-to-female ratio
for hip fracture incidence was 1·15:1 in contrast with
that of 0·34:1–0·43:1 in populations of most Western
countries(4). Differences are also found within the USA
between ethnic groups. Age-adjusted hip fracture rates
were reported to be 57/100000 in African-American
females, compared with 140/100000 in White-American
females(5), with similar trends for men(6). Also, Asian
and Hispanic men and women living in the USA have
lower hip fracture rates than their White-American coun-
terparts(5,7,8). It appears that across the world, White
populations are consistently reported to be at a higher
risk of fracture than other ethnic groups(2–4,7,8). These
differences cannot be fully explained by a lower bone
mass in White populations. While African-Americans
tend to have a higher bone mineral density than White-
Americans, this is not the case for Asian-Americans,
Asians or Africans. Fracture risk is multi-factorial and
only partly depends on bone mass. Other factors inﬂuen-
cing fracture risk are likely to be involved in the observed
ethnic differences in bone health.
The multitude of factors determining fracture risk can
be subdivided into extra-skeletal and skeletal factors. The
former include age, gender, neuromuscular coordination,
falls, and in the case of a fall, adiposity and soft tissue
cushioning may absorb the force and thus inﬂuence the
impact on the bone. Skeletal factors include bone mass,
geometry, the rate of bone turnover and mineral metab-
olism. Mineral and bone metabolisms are intimately
interlinked and this review focuses on ethnic variation
in the metabolism of the bone forming minerals, Ca
and phosphate (P).
Ca and P metabolism
Bone consists of an extracellular mineralised matrix
consisting of mineral salts (mainly hydroxyapatite
(Ca10(PO4)6(OH)2) crystals) bound to proteins. The
metabolic function of bone is crucial for Ca and
P homoeostasis. Ca, P and bone metabolism are regu-
lated by common factors, mainly parathyroid hormone
(PTH), 1,25-dihydroxy vitamin D (1,25(OH)2D) and
ﬁbroblast growth factor-23 (FGF-23). The parathyroid
gland detects the ﬂuctuations in plasma ionised Ca
(Ca2+) concentration through the Ca2+-sensing receptor.
In response to a reduction in plasma Ca2+, PTH is se-
creted by the parathyroid cells. In the kidney, PTH
binds to the PTH receptor and stimulates renal Ca reab-
sorption from the urinary ﬁltrate(9). This occurs through
a multitude of actions, including the increase of the renal
Na/K/Cl2 co-transporter to stimulate paracellular Ca
reabsorption, and through the transient receptor poten-
tial channel TRPV5, to stimulate luminal Ca trans-
fer(9,10). PTH also stimulates the renal conversion of
25-hydroxy vitamin D (25(OH)D) to 1,25(OH)2D via
the up-regulation of the enzyme 25-hydroxyvitamin-
D-1-α-hydroxylase. This, in turn, increases the
intestinal absorption of Ca and P. Both 1,25(OH)2D
and PTH act together to stimulate osteoblasts to pro-
duce factors that activate osteoclastic bone resorption(9),
liberating Ca and P into the extracellular ﬂuid(9). At
the same time, factors reﬂecting cellular function of
bone are released into plasma, known as bone turnover
markers.
FGF-23 is primarily a P-regulating hormone and
increases in response to a high plasma P and 1,25
(OH)2D
(11). In normal physiology, FGF-23 is mainly
produced by the osteocytes, but the FGF-23 mRNA is
also expressed in the osteoblasts and the bone lining
cells(12). FGF-23 acts on the kidney to increase renal P
excretion via down-regulation of the renal type-II trans-
porters, NaP-IIa and NaP-IIc in the proximal tubule.
In addition, FGF-23 acts to decrease the plasma
1,25(OH)2D
(11). The net effect is to decrease plasma P
concentration. This partly counteracts the potential
PTH- and 1,25(OH)2D-induced release of P from the
skeleton and the up-regulation of P absorption in the
intestine.
Although an elevated plasma PTH increases bone
turnover, the net effect on bone depends on the pattern
and the duration of exposure to a high plasma PTH. A
sustained high plasma PTH concentration due to pri-
mary or secondary hyperparathyroidism can lead to
bone loss, whereas anabolic effects occur with intermit-
tent exposures(13–16). Therefore, PTH may have contrast-
ing effects on the bone depending upon the length and
degree of exposure. The action of PTH may differ be-
tween different ethnic groups(17).
Modulators of Ca and P metabolism and their regulators
Hormonal regulation of mineral metabolism ensures
tight control of plasma Ca and P concentrations over
a wide range of nutrient intakes and absorption. The
plasma concentrations of the calciotropic hormones
are therefore inﬂuenced by dietary factors. Many other
factors inﬂuence their concentration. Kidney function
inﬂuences plasma PTH, FGF-23, 1,25(OH)2D and
25(OH)D concentrations(18). Plasma PTH is also
inﬂuenced by age, BMI and fasting(19). Plasma 25(OH)
D is further inﬂuenced by levels of skin exposure to
UVB-containing sunshine (related to clothing, sunscreen,
air pollution) and skin tone(20,21). Some of these modula-
tors are known to differ by ethnicity, reﬂecting differ-
ences in lifestyle, physiological or genetic factors.
Moreover, Ca and P metabolism exhibits variation
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is known as the diurnal rhythm (DR). Data comparing
the DR between ethnic groups are limited. They may
be expected to differ, as they are inﬂuenced by lifestyle
factors, and will be summarised later in this review.
Diurnal rhythms of Ca and P and regulators
DR refer to patterns of physiology, activity or behaviour
that follow the day–night cycles, and these may be
controlled by an underlying endogenous biological mech-
anism, known as the circadian rhythm(22). DR repeat
every 24 h and are associated with external factors
such as sleep–wake cycles, light–dark cycles, meals or
posture.
Biological data that follow a DR usually exhibit a
change over time in a smooth and continuous manner,
ascending to a maximum value, the peak and decreasing
to a minimum value, or nadir. The amplitude refers to
the variation over the day. The average value of a
measurement can be derived from the diurnal curve
and is referred to as the 24-h mean, as shown in Fig. 1.
The DR of Ca, P and bone metabolism is known to be
at least partially dictated by exogenous factors, such as
dietary and sleep–wake patterns. The majority of this re-
search has been conducted in White and Western
populations.
The diurnal rhythms of Ca and P metabolism. Plasma
total Ca is reported to have a nadir at night and a
day-time peak in men and women (see Fig. 2)(23,24). It
remains unclear whether this is related to the DR of
plasma albumin(24,25). Urinary Ca (as expressed in
mmol/h or as a ratio to urinary creatinine (uCa/uCr))
follows a signiﬁcant DR with a night-time nadir and a
day-time peak in both younger and older adults(24,26,27).
Plasma P tends to follow a DR with an increase during
the day, with a peak late in the evening and night and
a nadir in the early morning, both in post-menopausal
women(24) and healthy adult men and women(28).
Urinary P excretion (as measured by mmol/h or as
uP/uCr), exhibits a nocturnal nadir and a day-time
peak(24,26); this is consistent with the DR described for
uCa excretion. The nocturnal decrease in renal Ca and
P excretion is likely to partly reﬂect the biological
response to nocturnal fasting by conserving minerals at
the kidney level. The nocturnal decrease in urinary
mineral excretion may also be associated with the DR
in plasma PTH.
The diurnal rhythm of parathyroid hormone. Plasma
PTH concentration exhibits a well-documented DR
with two peaks in healthy people, one in the afternoon/
evening, and one at night (see Fig. 2)(23,24,26,29). The
timing of the nocturnal peak of plasma PTH
concentration corresponds to a decrease in uCa/uCr
excretion and (with a time lag) to the decrease in uP/
uCr(26). This is suggestive of a physiological role for the
DR of PTH in regulating renal Ca and P excretion(26).
Studies of the pathological conditions have shown
changes in the DR of PTH(25,30–32). A comparative
study between osteoporotic and healthy women reported
a signiﬁcant DR of PTH in both the groups, but with dif-
ferences observed between the groups(33). In osteoporotic
women, there was a higher 24-h mean of plasma PTH
concentration with a smaller nocturnal increase, and
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Fig. 1. Schematic representation of the diurnal rhythm of
biological data.
Fig. 2. Diurnal variation in total plasma Ca (albumin-adjusted:
bold lines and unadjusted: broken line), phosphate (P) and
parathyroid hormone (PTH) (change from 24 h mean, % mean and
SEM) in healthy post-menopausal women. P-value indicates the
signiﬁcance of the diurnal variation. Reproduced from(25) with
permission. Figure 2 was granted permission for reproduction by
Copyright Clearance Center’s RightsLink service by the European
Journal of Endocrinology. License no.: 3213570527941.
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the nocturnal peak occurred at an earlier time compared
with healthy women(33). These ﬁndings suggest that the
DR of plasma PTH may be important for overall mineral
and bone metabolisms. The physiology of the DR of
plasma PTH has been reviewed elsewhere in detail(32).
The diurnal rhythms of 1,25(OH)2D, vitamin D
binding protein and ﬁbroblast growth factor-23. Plasma
1,25(OH)2D and vitamin-D-binding-protein were found
to have a signiﬁcant DR in postmenopausal women,
although the free fraction of 1,25(OH) 2D (i.e. not bound
to the vitamin-D-binding-protein) did not vary over
the 24-h cycle(24). Only one study is available which
investigates the DR of FGF-23 and has reported
that FGF-23 did not have any signiﬁcant DR in healthy
children and adults and patients with X-linked
hypophosphataemia, although a signiﬁcant DR was
observed for its biological co-factor, Klotho(34).
The diurnal rhythms of bone turnover markers. Bio-
chemical markers of bone turnover exhibit a DR, with
a night-time peak and a day-time nadir(23,35–37). In a
study of healthy men, the bone resorption marker,
carboxy-terminal-collagen-crosslinks had a night-time
peak that was 66% greater than the 24-h mean(37). The
DR of the bone formation markers osteocalcin and
the bone-alkaline-phosphatase exhibits less variation
than the DR of bone resorption, and the amplitude is
typically only 10–20% of the 24-h mean(23,38); which
may relate to the differences in metabolism or excretion
of the markers(35).
The DR of the bone turnover markers is partially
dictated by exogenous factors; it is altered by fasting
and food intake(35,39,40). It was reported that plasma
concentrations of the bone resorption marker carboxy-
terminal-collagen-crosslinks, and to a lesser extent the
bone formation markers procollagen-type-I-N-terminal-
propeptide and osteocalcin, were signiﬁcantly higher
after 9 h fasting compared with the fed state(35). There
are acute post-prandial changes in bone turnover that
may be associated with changes in the activity of mature
bone cells(40). Potential mediators of this response in-
clude calciotropic hormones, growth hormone, pancre-
atic peptides and incretin hormones. The DR of bone
resorption has also been described to be modulated
by the pattern of dietary Ca intake(41–43). Further infor-
mation may be found in a recent review(40).
Ahmad et al. reported an association between the
DR of plasma concentrations of PTH and bone turnover
markers; the timing of the peak concentrations of the
carboxy-terminal-collagen-crosslinks and the procolla-
gen-type-I-N-terminal-propeptide lagged behind the
peak concentration of PTH by about 3 h(25). The results
of this study suggest that PTH may have some regulatory
role in the DR of bone resorption and formation, as
reﬂected by the markers of the bone turnover(25),
although this has not been consistently seen(29).
Taken together, these results suggest the homoeostasis
of plasma Ca at night, in the absence of Ca intake, is
maintained by an enhanced bone resorption and also
by an enhanced renal reabsorption of Ca(44). This homo-
eostasis is in part, but not completely, mediated via a
nocturnal increase in plasma PTH. Differences in DR
of Ca, P and bone metabolisms between healthy indivi-
duals and patients with osteoporosis are reported(30,31),
particularly in PTH and uCa excretions. This indicates
that they may be important for Ca balance and skeletal
integrity.
Little is known about the inﬂuence of ethnicity on
these DR. Differences may be expected between ethnic
groups due to differences in lifestyle factors, including
the timing of sleep–wake patterns, the pattern of dietary
intake and total dietary intake. Differences in dietary in-
take and other factors associated with Ca and P metabo-
lisms may vary considerably between ethnic groups, and
will be discussed in this review.
Ethnic differences in Ca and P metabolism
Ethnic differences in dietary intake
Differences in food availability, cultural preferences and
socioeconomic factors contribute to differences in dietary
intake between ethnic groups within and between
countries.
Ca is present in a wide range of foods, although the
bioavailability varies depending on the source. Milk
and milk products have a high Ca content. Plant sources
of Ca include pulses, whole-grains, nuts, some dried fruit,
tofu and green vegetables. On the population level,
Ca intakes can vary by approximately 5-fold depending
on the types of foods consumed(45). They range from
very low intakes (200–400mg/d) in some parts of Asia
(e.g. China, Japan) and Africa (e.g. The Gambia,
Kenya)(46–51) with Ca from vegetables, legumes, cereals
and nuts accounting for much of the intake(46,51) to
higher intakes in mostly White populations (>750mg/d)
of the USA, the UK and the Northern European
countries(52–54).
Protein-rich foods (milk, meat, poultry and ﬁsh) and
cereal grains provide the majority of dietary phosphorus
intake(55). The Ca:P ratio may be important, but little
is known about their ethnic differences in dietary Ca:P
ratio. Spencer et al., showed that although Ca balance
did not change with varying intakes of dietary P, the
higher P intake resulted in a signiﬁcant decrease of the
daily uCa output(56). This may be related to the lower
availability of Ca for intestinal absorption due to its
binding to P. The effect of the dietary Ca:P ratio on
bone health is inconclusive.
Differences in dietary intake may exist between the
ethnic groups living in the same geographical region,
for example, within the USA, as detailed in the next sec-
tion. Within the UK, 42% of women of African or
Caribbean origin, and 36% of women of South-Asian
or other Asian ethnic origin had Ca intakes below
the lower reference nutrient intake, compared with only
8 % of White-British women(52,57). Also, a Canadian
study comparing Western-born Chinese, recent Chinese
migrants to Canada and White-Canadians found differ-
ences in the macro- and the micro-nutrient intakes be-
tween these groups(58).
In the remainder of this review, we will focus on selec-
ted ethnic groups, describing Ca and P intake and the
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inﬂuence this has on Ca and P regulation and bone
metabolism. The focus will be to compare and contrast
Ca and P metabolism between: (a) African-American
and White-Americans in the USA, as an example of
the differences between groups in the same geographical
location; (b) African in the Gambia and White-British
in the UK and (c) Chinese in Northern China and
White-British in the UK, as examples of differences be-
tween the ethnic groups living in their environment of
origin.
Ethnic differences in Ca and P metabolism:
African-Americans compared with White-Americans
Ethnic differences in dietary Ca and P intakes in the
USA. Within the USA, ethnic groups differ in dietary
Ca intake. White-Americans have a Ca intake close
to the recommendations (∼900mg/d), while African-
Americans have a lower Ca intake at all stages of life,
as documented in the National Health and Nutrition
Examination Survey(53) and other studies(44,59). African-
Americans are reported to consume the same or less
dietary P than White-Americans(60).
Some studies have reported greater fractional and total
intestinal Ca absorption in African-Americans compared
with White-American children and adolescents(61,62).
However, Bell et al. did not ﬁnd any differences in frac-
tional intestinal Ca absorption, despite the ﬁnding of
lower serum 25(OH)D concentration and 24-h uCa
excretion and higher serum 1,25(OH)2D in African-
Americans than in White-American adolescents(63).
Ethnic differences in 25(OH)D in the USA. After
exposure to a single standard dose of UV radiation,
there is less dermal synthesis of vitamin D3 from
7-dehydrocholesterol in darker skin because of the
absorption of UVB-light by the skin pigment(64),
although the total capacity appears to be similar in
African-Americans and White-American young adults
when exposed to unlimited sunshine(65). Consequently,
when living in temperate climates, darker skinned
individuals tend to have lower plasma 25(OH)D
concentrations. This is reﬂected in data obtained within
the USA, including the National Health and Nutrition
Examination Survey, where for similar amounts of
UVB-containing sunshine exposure, African-Americans
have lower 25(OH)D in winter and summer(59,66,67).
The lower plasma 25(OH)D concentration may also
be partly explained by a higher BMI on average in
African-Americans, as BMI is inversely associated with
plasma 25(OH)D(68). However, Coney et al. report that
ethnic differences in plasma 25(OH)D remain after ad-
justment for body weight, percentage body fat and
BMI(69). The lower 25(OH)D may be possibly explained
partly by genetic variations in vitamin D synthesis, the
vitamin-D-binding-protein and/or metabolism between
ethnic groups(66,70).
Ethnic differences in regulatory hormones in the
USA. Plasma PTH, 1,25(OH)2D and urinary cyclic-
adenosine-3′,5′-monophosphate (an indicator of renal
PTH activity) have been reported to be higher in
African-Americans compared with White-American
adults(71–73). A lower vitamin D status, in addition to a
lower Ca intake, may explain these ﬁndings(72), since
PTH is a primary regulator of Ca metabolism, as
described earlier. The higher plasma PTH in African-
Americans, however, may not lead to a similarly
increased rate of bone turnover or risk of osteoporosis
as it does for White-Americans. A comparative study
of African-American and White-American women
matched for age and weight, reported that, despite
having lower plasma 25(OH)D and higher plasma PTH,
African-American women have a higher bone mineral
density and bone mineral content and lower bone
turnover rate(59). This was conﬁrmed by other studies
reporting lower concentrations of bone turnover markers
in African-Americans despite a similar or higher plasma
PTH as White-Americans(72,74). This is further
underpinned by the results of a controlled PTH infusion
study showing a lower rise in the markers of bone
resorption in African-American compared with White-
American premenopausal women in response to the
same amount of infused PTH(17). Furthermore,
histomorphometric analysis of biopsies of the iliac
crest after double-tetracycline labelling showed that the
bone formation rate in African-American adults was
only one-third that of White men and women(75). In
addition, the relationship between plasma 25(OH)D
concentration and bone outcomes differs by ethnicity; a
lower plasma 25(OH)D is associated with a lower bone
mineral density in White-Americans, but not African-
Americans(67). Taken together, these pieces of evidence
suggest that the bone resorptive response to PTH differs
between these groups, and it has been suggested that
African-Americans have a relative skeletal resistance to
PTH(67).
Ethnic differences in renal mineral excretion in the
USA. Studies comparing ethnic groups in the USA
have shown that the African-American adults have
lower daily uCa and uP excretions across all
ages(59,62,72,76). Postmenopausal African-American
women excrete on average 65mg less uCa/d and 120mg
less uP/d than White-American women(77). In steady-
state conditions of mineral ion balance, the daily urinary
mineral excretion equates to net absorption from dietary
sources(76); accordingly, it has been speculated that the
lower urinary mineral excretion among African-
Americans is due to a lower intestinal absorption of Ca
and P. This, however, needs to be interpreted with
consideration of dietary intake. As mentioned earlier,
when compared with White-Americans, African-
Americans consume less dietary Ca and the same or less
dietary P(60). It has been demonstrated in adolescents
and adult women that lower daily uCa excretion in
African-Americans is primarily determined by a higher
renal Ca conservation rather than lower fractional
intestinal Ca absorption(63,78). These differences cannot
be fully explained by a higher plasma PTH and a
1,25(OH)2D concentration in African-Americans. A
lower 24-h Ca excretion was reported in African-
Americans compared with White-American adolescent
girls across a range of controlled dietary Ca intakes,
and at similar concentrations of plasma 25(OH)D,
J. Redmond et al.344
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(62). This was conﬁrmed by a study
by Gutierrez et al. examining ethnic differences in
postprandial urinary fractional mineral excretion
between African-American and White-American adults
in samples collected for 4 h following a standardised
meal(76). Despite similar plasma PTH and FGF-23
concentrations, African-Americans had ∼35 % lower
fractional Ca excretion and ∼30% lower postprandial
fractional P excretion than White-Americans(76). These
pieces of evidence suggest that African-Americans have
a proportionally higher renal mineral conservation than
White-Americans.
Overall, there appears to be strong evidence support-
ing the biologically relevant ethnic differences across all
aspects of Ca and P metabolism and in the concentra-
tions and responses to the regulators between African-
Americans and White-Americans. The differences
described in the skeletal responsivity to PTH, the rate
of bone remodelling and the differences in Ca and P
retentions may be associated with ethnic differences in
bone mass and fracture risk (Table 1).
Ethnic differences in Ca and P metabolism: The Gambia
v. the UK
Ethnic differences in dietary intake: The Gambia v. the
UK. Dietary Ca intake in The Gambia, West Africa, is
very low (200–400mg/d)(47,79,80). The main contributors
to daily Ca intake are leaves, ﬁsh, locust beans, cereals,
groundnuts and local salt, while milk is reported to
account for only 5 % of Ca intake(46). In the UK, milk
and milk products contribute substantially to dietary
Ca intake (approximately 56 %). Daily Ca intake is
generally close to recommendations (760–960mg/d) with
some regional variations(52). We have previously
reported that the dietary Ca and Ca:P intakes were lower
in rural Gambian compared with White-British
adolescents and older adults from Cambridge(47,80).
Ethnic differences in 25(OH)D: The Gambia v. the
UK. Vitamin D status in The Gambia is generally
higher than in the UK. Plasma 25(OH)D was reported
to be 60–100nmol/l in Gambian men and women
throughout the year across all ages and in
pregnancy(21,80–83). In the UK, vitamin D status
undergoes seasonal variation. The UK National Diet
and Nutrition Survey reported mean annual 25(OH)D
concentrations as 45·6 (SD 22·6)nmol/l for men and 49·6
(SD 25·6)nmol/l for women aged 19–64 years(84).
Ethnic differences in regulatory factors: The Gambia v.
the UK. Plasma PTH and 1,25(OH)2D concentrations
are raised in Gambians compared with White-British
subjects, and this is likely the result of their very low
Ca intake(80,82,85). A higher plasma PTH in the
Gambia is found in conjunction with higher plasma
concentrations of markers of osteoblast activity, with
or without the concomitant higher markers of
osteoclast activity(47,82). Therefore, it appears that the
higher plasma PTH in The Gambia is associated with
greater bone turnover, which is similar to the ﬁndings
reported in South Africans(86), but is in contrast to the
lower bone turnover and the reported skeletal resistance
in African-Americans(17). These ﬁndings are conﬁrmed
by a detailed study investigating the bone response
after oral-P-induced PTH secretion(47). This study
showed no proportional differences between Gambians
and White-British adults in the skeletal response to a
raised plasma PTH(47), suggesting no difference in their
relative skeletal sensitivity to PTH.
In White-British and other White populations, a high
plasma PTH has been shown to be related to a lower
hip bone mineral content(87) and pathologically elevated
plasma PTH is a signiﬁcant risk factor for osteoporosis
and fracture(88). In contrast, the chronically raised
plasma PTH concentration that has been reported in
the adults from The Gambia(80,82,85), is not associated
with a high incidence of fracture on a population
level(89). Schnitzler suggested that high bone turnover
may remove fatigue damage and improve bone qual-
ity(86) and is a plausible explanation for the very low
fracture rates in West Africa.
Ethnic differences in renal mineral excretion: The
Gambia v. the UK. There is evidence for differences in
renal mineral conservation between The Gambia and
the UK. Aspray et al. found that the 24-h uCa and uP
outputs were both signiﬁcantly lower in the rural
Gambian adult women, particularly after menopause,
compared with White-British women(82). Further
investigations of renal Ca handling and the inﬂuence of
dietary intake in elderly men and women from the
Gambia and the UK showed that the 2-h fasting uCa/uCr
excretion was signiﬁcantly lower in Gambian subjects.
The UCa/uCr remained lower in Gambian subjects
even after statistical adjustment for dietary Ca intake
and for glomerular ﬁltration rate, body weight, height
and body surface area(90). There were also differences
in the fractional excretion of Ca (i.e. the percentage
of Ca ﬁltered by the kidney which is excreted in
the urine), and in the tubular maximum of Ca (i.e. the
maximum renal tubular mineral reabsorption, a
threshold beyond which Ca is excreted in the urine)(90).
Similar trends were observed for uP and these
differences also remained after statistical adjustment for
dietary intake.
Taken together, these pieces of evidence suggest im-
portant differences in the Ca and P regulatory axes
Table 1. Factors associated with ethnic differences in Ca, P and
bone metabolism within the USA
Parameter
African-Americans
v. White-Americans*
Osteoporosis/fracture risk(5–7) 
Dietary Ca(44,53,59) 
Dietary P(60) /=
Plasma 25(OH)D(59,66,67) 
Plasma 1,25(OH)2D
(71–73) 
Plasma PTH(59,71–74) 
Bone turnover markers(59,74) 
Renal Ca and P excretion(59,72,77) 
PTH, parathyroid hormone.
* Arrows indicate the differences compared with White-Americans.
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between White-British and Gambian adults, and between
Gambians and African-Americans.
Ethnic differences in Ca and P metabolism:
China v. the UK
There are fewer data available on the differences between
White-European and Chinese populations. The limited
data available are summarised below.
Ethnic differences in dietary intake: China v. the
UK. The traditional Chinese diet is low in Ca because
of the low consumption of milk and milk products; Ca
intake comes mainly from the consumption of green
vegetables, legumes, cereals and small ﬁsh(51,91). There
is also considerable geographical dietary variation
within China(48). Hu et al. reported that the mean Ca
intake ranged from 200 to 700mg/d depending on the
region(48). Zhang et al. reported an increasing trend in
the daily intake of Ca in Chinese adults between 1991
and 2009. Despite this, the average Ca intake in 2009
was 400 and 352mg/d for men and women,
respectively(51). Other studies report Ca intakes were
typically below 500mg/d(92,93). We have previously
reported that older Chinese adults in Shenyang,
Northern China have lower dietary Ca and P intakes
and a lower dietary Ca:P ratio compared with their
White-British counterparts(47).
Ethnic differences in 25(OH)D: China v. the
UK. Zhang et al. reviewed publications measuring
the plasma 25(OH)D in China in various age groups
and in different areas of China(94). It was found that
the vitamin D deﬁciency (deﬁned as plasma 25(OH)D
concentration <25nmol/l) is observed in the Chinese
population in almost all age groups and areas. For
example, a high prevalence of deﬁciency was reported
in Beijing (40°N) in the autumn and in Nanjing
(latitude 31°N) during the winter months(94). In women
from Nanjing, the mean plasma 25(OH)D
concentrations were 22 and 32nmol/l in the winter and
the summer, respectively(95). In our studies, we have
also reported signiﬁcantly lower plasma 25(OH)D
concentrations in the Chinese men in Shenyang (42°N)
compared with their White-British counterparts in
Cambridge (52°N) in late winter but not in summer(87).
The aetiology of vitamin D deﬁciency in China is
likely to be multifactorial. At latitudes >30°N, there is
little to no cutaneous synthesis of vitamin D during
the winter; the length of the ‘UVB winter’ depends on
the latitude and is longer further in the North(96). In ad-
dition, there may be avoidance of skin exposure to
UVB from sunshine for cultural reasons, and high levels
of air pollution in some areas(94). Foods rich in vitamin
D in the Chinese diet are scarce, and there is limited
availability or consumption of vitamin D fortiﬁed
products(94).
Ethnic differences in the regulatory factors: China v.
The UK. We have previously reported that Chinese
adults from Shenyang, Northern China had a higher
plasma PTH concentration than White-British adults
in winter months(87), although no ethnic differences
were reported in data from the summer and winter
combined(47). This ﬁnding is a likely result of lower
Ca intake and, in winter, a lower plasma 25(OH)D
in older Chinese adults than in White-British
counterparts(47,87). The relationship between plasma
PTH and 25(OH)D differed between the two ethnic
groups; Chinese adults had a higher plasma PTH for a
given plasma 25(OH)D concentration(87). In older
White-British adults, a negative relationship between
PTH and the size-adjusted bone mineral content at the
femoral trochanter (after adjustment for confounders)
was observed, but this relationship was not seen in
older Chinese adults (Fig. 3)(87). This ﬁnding was
supported by a previous study of elderly men and
women from Hong Kong where the bone mineral
density at the spine and the hip was not associated with
plasma PTH(97). This suggests that older Chinese adults
may have a degree of resistance to the bone resorptive
effects of PTH. This was however, not conﬁrmed by
a detailed study by Yan et al., as described in the
next section.
Ethnic differences in renal mineral excretion: China v.
The UK. There are few studies available directly
comparing the differences in renal excretion in these
ethnic groups. The comparative results obtained from
the 2-h fasting urine samples collected from
older Chinese and White-British adults suggested that
there were no differences in either the uCa/uCr or the
uP/uCr(47). Yan et al. investigated the potential skeletal
resistance to PTH in older Chinese adults compared
with older White-British adults by conducting a 5-d
oral-P loading study to stimulate PTH secretion(47). No
evidence was found for the differences in the skeletal
response to PTH and the results did not support the
Fig. 3. The relationship between Ln parathyroid hormone (PTH)
and Ln bone mineral content (BMCt) at the femoral trochanter
adjusting for bone area, weight, height, age and sex in Shenyang
(x) and Cambridge (.) subjects. Reprinted from(88) with permission
from Elsevier. Figure 3 was granted permission for reproduction by
Copyright Clearance Center’s RightsLink service by Elsevier.
License no.: 3196500798854.
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hypothesis of skeletal resistance to PTH in older Chinese
adults compared with older British adults. However,
a potentially important difference in the renal response
to PTH was found, which was greater in the Chinese
group, resulting in more rapid P clearance compared
with White-British(47).
Summary: ethnic differences in Ca and P metabolism
Older people from the Gambia and China have a lower
Ca intake and concomitantly higher plasma PTH and
1,25(OH)2D concentrations than those from the UK.
Yet, unlike in White-British adults, where a high PTH
is considered to be a risk factor for osteoporotic fracture,
this is not seen in Gambia and China, where the rates of
fracture are lower than in the UK. However, while skel-
etal resistance to PTH is described in African-Americans,
this has not been demonstrated in the small studies in
older Gambian or Chinese adults.
Ethnic differences in the diurnal rhythms of Ca and
P metabolism
Most of the evidence on the ethnic differences in Ca and
P metabolism is derived from studies that have per-
formed investigations under fasting conditions and at
standardised times of the day, generally in the early to
mid-morning. However, the markers of Ca and P metab-
olism exhibit a DR, as previously described. By limiting
blood or urine sampling to one timepoint along a ﬂuctu-
ating pattern, group differences in the DR or the 24-h
mean may go undetected. Little is known about ethnic
differences in these DR and their potential inﬂuences
on the net mineral balance and skeletal health, respect-
ively. Differences in the DR may be anticipated due to
known lifestyle differences, such as the total and the pat-
tern of dietary Ca and P intakes, sleep/wake patterns,
which are related to known differences in plasma con-
centrations of PTH and bone turnover markers between
ethnic groups.
There is some evidence, albeit limited, to suggest
ethnic differences in the DR of PTH and uCa excretion
between African-American and White-American
women(44). In the single study investigating these differ-
ences, the 24-h mean of plasma PTH concentration was
higher in African-Americans and their plasma PTH con-
centration did not change signiﬁcantly between day-time
and night-time, although uCa excretion (mmol/8h) was
lower at night compared to the day-time. In contrast,
White-American women had a signiﬁcant night-time
increase in plasma PTH concentration and a more pro-
nounced nocturnal decrease in uCa (mmol/8h) than
African-Americans. The differences suggest a higher
renal conservation of Ca during the day in African-
American compared with their White-American
counterparts(44).
This study also demonstrated that ethnic differences in
Ca and P metabolism between African-American and
White-American women depend on the time of the
day. African-Americans had signiﬁcantly lower uCa
and uP (mmol/4h) compared with White-Americans as
measured in the morning and the day-time samples, re-
spectively, but there were no ethnic differences found in
uCa or uP (mmol/8h) in the samples collected during
the night(44).
This highlights the importance of considering the
inﬂuence of the DR in ethnic comparative research.
Therefore, in the interpretation of the differences be-
tween ethnic groups, the timing of sample collection
needs to be considered. These differences may relate to
the timing of the peaks and the nadirs, the amplitude
or the 24-h means of the measures of Ca, P and bone
metabolism. Also, this may relate to the responses of
the bone and kidney to the regulators, which may inﬂu-
ence the net effect on Ca and P balances. To address
this, we are conducting a comparative study comparing
the DR of Ca and P metabolism between older adults
from three ethnic groups.
The investigation of ethnic differences in the diurnal
rhythms of Ca and P metabolism
In order to investigate the potential ethnic differences
in the DR of Ca and P, we are investigating mineral
and bone metabolism in three different ethnic groups:
White-British, Gambian and Chinese older adults.
Each ethnic group is investigated in their habitual en-
vironment, thus allowing the participants to follow their
normal daily routine. The participants are healthy older
men and women (60–75 years). The habitual intake of
key nutrients and the timing of their intake are assessed
by using methods appropriate to each country, and a
sleep/wake pattern questionnaire is administered. Blood
samples are collected at 4-h intervals; participants were
divided into two groups with a 2-h shift in their sampling
times to allow for the analysis of 12 time-points over 24 h
(Fig. 4). A 24-h urine collection was carried out, which
was divided into seven separate timed collections. The
study design allows for the analysis of Ca and P metab-
olism in the early morning fasting samples, as commonly
Fig. 4. Timings of blood and urine collections.
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collected in ethnic comparative research, but also the
non-fasting samples at standardised times of the day.
Biochemical analyses were performed for the markers
of the mineral and the bone metabolism, and their
regulators. Data analyses are currently ongoing.
The results of this study will provide information
about ethnic differences in Ca, P and bone metabolism,
the importance of the sampling time in ethnic compara-
tive research and the potential inﬂuence of the DR on the
differences in Ca and P metabolism. This will potentially
provide mechanistic insights into ethnic differences in
mineral and bone metabolism.
Conclusion
There are striking differences in Ca and P metabolism
between ethnic groups, as described by using examples
of the differences between the groups within the USA,
and between the groups in different countries (The UK,
The Gambia and China). These differences in Ca and
P metabolism may be associated with the known differ-
ences in bone health in older age between these ethnic
groups.
Few studies have taken into account the DR of Ca and
P metabolism, which are potentially different between
groups, as they may be inﬂuenced by differences in ex-
ogenous factors such as sleep and wake patterns
and the absolute amounts and patterns of dietary intake
of key nutrients.
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